Michio Hirano MD

Neurology•New York, NY

Neuromuscular Medicine

Professor, Pathology; Neuroscience, Albert Einstein College of Medicine

Request appointment

710 West 168th StreetNew York, NY 10032
Book by Phone+1(551) 357-0144

Overview of Dr. Hirano

Dr. Michio Hirano is a neurologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Albert Einstein College of Medicine and has been in practice 40 years. Dr. Hirano accepts several types of health insurance, listed below. He is one of 519 doctors at New York-Presbyterian Hospital and one of 261 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Neurology. He has more than 100 publications and over 500 citings.

Education & Training

New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 1987 - 1990
Jacobi Medical CenterInternship, Transitional Year, 1986 - 1987
Albert Einstein College of MedicineClass of 1986
New York Presbyterian Hospital (Cornell Campus)Fellowship, Neuromuscular Medicine (Neurology)

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

FL State Medical License 2023 - Present
NY State Medical License 1987 - 2028
NJ State Medical License 2017 - 2027
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification NYP Quality Analytics, Ambulatory, NewYork-Presbyterian Hospital, 2014-2017
CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR, Allscripts, 2014-2017
CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR (Complete), Allscripts, 2014-2017

Clinical Trials

Study of Idebenone in the Treatment of Mitochondrial Encephalopathy Lactic Acidosis & Stroke-like Episodes
COMPLETED
PHASE2
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC) Start of enrollment: 2011 Jan 31
RECRUITING
The Natural History Study of Mitochondrial NeuroGastroIntestinal Encephalopathy (MNGIE)
RECRUITING

Publications & Presentations

PubMed

Comprehensive functional testing in fibroblasts has strong utility to diagnose mitochondrial disease.
Johan L K Van Hove, Marisa W Friederich, Roxanne A Van Hove, Jessica C Lee, Kaz M Knight
EMBO Molecular Medicine. 2026-09-08
Progress and perspectives in primary mitochondrial myopathy: Highlights from the 2025 mitochondrial medicine masterclass with a focus on TK2 deficiency.
Austin Larson, Jared Goettemoeller, Ken Goettemoeller, Linda Goettemoeller, Amy Goldstein
Therapeutic Advances in Rare Disease. 2026-09-03
1 citations
Use of nucleoside therapy for mitochondrial DNA depletion/deletion syndrome (MDDS).
Michio Hirano, Andres Berardo, Emanuele Barca, Valentina Emmanuele, Austin Larson
Neurotherapeutics. 2026-09-01

Journal Articles

A Novel Complex Neurological Phenotype Due to a Homozygous Mutation in FDX2
Michio Hirano, MD, Brain

Press Mentions

UCB Drug Becomes First FDA-Approved Treatment for Ultra-Rare and Fatal Mitochondrial DiseaseNovember 5th, 2025
Senior Researcher Spotlight: Fernando Scaglia Explores Novel Therapeutic Approaches for Mitochondrial DisordersJune 7th, 2022
Consortium Spotlight: Advancing Discoveries in Mitochondrial DiseasesJune 1st, 2022

Grant Support

The North American Mitochondrial Disease Consortium (NAMDC)COLUMBIA UNIVERSITY HEALTH SCIENCES2011–2025

Professional Memberships

American Academy of Neurology - AAN
Member

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
Great West PPO
Healthfirst New York
HIP of New York - Select PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment